fate therapeutics inc stock price

According to the current. Is performing with stock quotes.

Fate Therapeutics Fate Stock Price News Info The Motley Fool

Volume today is light.

. The stock has a market. Their forecasts range from 6000 to 11600. Stock information by Barrons.

Company profile page for Fate Therapeutics Inc including stock price company news press releases executives board members and contact information. So far 957137 shares have traded compared to average volume of 1417572 shares. Learn about Fate Therapeutics Inc FATEXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and other stock information.

HC Wainwright Adjusts Fate Therapeutics Price Target to 115 from 122 Keeps Buy Rati. View the latest Fate Therapeutics Inc. Fate Therapeutics stock price target raised to 79 from 58 at Stifel Nicolaus Dec.

Real time Fate Therapeutics FATE stock price quote stock graph news analysis. Find the latest Fate Therapeutics Inc. Complete Fate Therapeutics Inc.

Common Stock FATE Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. May 6 11943 PM GMT-4 USD NASDAQ Disclaimer. As of 1208pm ET.

RT Quote NASDAQ USD. Fate Therapeutics Inc. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

FATE 2326 049 206 5744. Fate Therapeutics Inc FATE stock is trading at 2373 as of 400 PM on Tuesday May 17 an increase of 109 or 481 from the previous closing price of 2264. Chart FATE THERAPEUTICS INC.

BATS BZX Real-Time Price. Get a full understanding of how Fate Therapeutics Inc. ETF Daily News 5 hrs ago.

Last 051022 EDT. 102 rows Discover historical prices for FATE stock on Yahoo Finance. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.

FATE stock quote history news and other vital information to help you with your stock trading and investing. ET by Tomi Kilgore Fate Therapeutics stock price target raised to 88 from 55 at Wedbush. Find the latest Fate Therapeutics Inc FATE stock market data.

NASDAQFATE Get Rating Research analysts at SVB Leerink boosted their FY2026 EPS estimates for Fate Therapeutics in a research note issued to investors on Tuesday. Fate Therapeutics Inc. View real-time FATE stock price and news along with industry-best analysis.

View daily weekly or monthly format back to when Fate Therapeutics Inc. Wall Street brokerages predict that Fate Therapeutics Inc. The stock has traded between 2288 and 2405 so far today.

This suggests a possible upside of 2676 from the stocks current price. Fate Therapeutics Inc. The firm has a fifty day moving average price of 3383 and a 200 day moving average price of 4270.

FATE stock price news historical charts analyst ratings and financial information from WSJ. HC Wainwright Lowers Fate Therapeutics NASDAQFATE Price Target to 11500. View analysts price targets for Fate Therapeutics or view top-rated stocks among Wall Street analysts.

A high-level overview of Fate Therapeutics Inc. The low in the last 52 weeks of Fate Therapeutics stock was 2049. NASDAQFATE - Get Rating - Research analysts at SVB Leerink boosted their FY2026 earnings per share EPS estimates for shares of Fate Therapeutics in a report released on Tuesday May 17th.

NASDAQFATE Get Rating will announce earnings of 086 per share for. More About Fate. On average they expect Fate Therapeutics share price to reach 8722 in the next twelve months.

Wedbush Adjusts Fate Therapeutics Price Target to 77 From 74 Keeps Outperform Ratin. 7 2020 at 750 am.

The Rally Likely To Continue For Fate Therapeutics After Positive Clinical Trials Data